A new report released today by the Charlotte Lozier Institute (CLI) analyzes funding for stem cell research in California and Maryland to conclude that funding trends reflect the scientific community’s view that the best hope for disease treatment and therapies lies with morally unproblematic, non-embryonic stem cells.
“For decades, stem cells obtained by destroying unique, living human beings were heralded for their potential ability to cure numerous diseases and conditions. However, while funding for this morally objectionable research initially boomed, efficacious therapies did not,” said Chuck Donovan, president of the Charlotte Lozier Institute.
“Tracking of funding trends both at the California Institute for Regenerative Medicine (CIRM) and in the state of Maryland shows a decisive change in strategy. Money talks – and our new report shows a growing preference to fund ethical stem cell projects nationwide. This reflects the scientific community’s belief that the best hope for rapid medical advances lies with morally unproblematic alternatives.”
CLICK LIKE IF YOU’RE PRO-LIFE!
This is the second report in a Lozier Institute series analyzing stem cell funding trends across a variety of states. The California Institute for Regenerative Medicine and the State of Maryland have both been strong advocates for embryonic stem-cell research.
The Charlotte Lozier Institute was launched in 2011 as the education and research arm of Susan B. Anthony List. The CLI is a hub for research and public policy analysis on some of the most pressing issues facing the United States and nations around the world. The CLI website features commentaries, reviews and blog posts by an array of policy experts and scholars whose work covers statistics, medicine, bioethics, health care and law.